BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+5.37%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$1.94B
AUM Growth
+$1.94B
(+3.6%)
Cap. Flow
+$38.3M
Cap. Flow
% of AUM
1.97%
Top 10 Holdings %
Top 10 Hldgs %
80.83%
Holding
24
New
1
Increased
6
Reduced
8
Closed
–
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$21.7M |
| 2 |
Puma Biotechnology
PBYI
|
$12.3M |
| 3 |
Halozyme
HALO
|
$11.6M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$9.31M |
| 5 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$6.74M |
Top Sells
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$9.8M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$5.01M |
| 3 |
Incyte
INCY
|
$4.67M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$4.56M |
| 5 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$4.29M |
Sector Composition
| 1 | Healthcare | 87.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $305M | 15.72% | 2,184,649 +155,378 | +8% | +$21.7M |
|
|
2
Ionis Pharmaceuticals
IONS
$6.8B
| $272M | 14.04% | 6,301,526 -116,022 | -2% | -$5.01M |
|
3
Gilead Sciences
GILD
$140B
| $249M | 12.83% | 3,513,496 -34,218 | -1% | -$2.42M |
|
|
4
Incyte
INCY
$16.5B
| $221M | 11.4% | 4,133,790 -87,297 | -2% | -$4.67M |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $111M | 5.7% | 727,428 -30,000 | -4% | -$4.56M |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $99.3M | 5.12% | 1,404,445 | – | – |
|
|
MDVN
7
DELISTED
MEDIVATION, INC.
MDVN
| $94M | 4.84% | 1,459,706 -20,000 | -1% | -$1.29M |
|
|
GEVA
8
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $78M | 4.02% | 939,957 +81,200 | +9% | +$6.74M |
|
|
9
Halozyme
HALO
$8.56B
| $71.7M | 3.69% | 5,641,564 +916,628 | +19% | +$11.6M |
|
|
10
Regeneron Pharmaceuticals
REGN
$61.5B
| $67M | 3.45% | 223,000 +31,000 | +16% | +$9.31M |
|
|
PCYC
11
DELISTED
PHARMACYCLICS INC
PCYC
| $63.8M | 3.29% | 636,542 | – | – |
|
|
ECYT
12
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $58.7M | 3.02% | 2,463,522 -180,000 | -7% | -$4.29M |
|
13
Neurocrine Biosciences
NBIX
$13.8B
| $48.2M | 2.49% | 2,996,552 +350,000 | +13% | +$5.63M |
|
|
IMGN
14
DELISTED
Immunogen Inc
IMGN
| $47.3M | 2.44% | 3,165,816 -60,000 | -2% | -$896K |
|
|
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
| $33.8M | 1.74% | 488,188 | – | – |
|
16
Alnylam Pharmaceuticals
ALNY
$58.5B
| $31.6M | 1.63% | 471,288 | – | – |
|
17
Innoviva
INVA
$1.29B
| $27.5M | 1.42% | 888,244 | – | – |
|
|
TSRO
18
DELISTED
TESARO, Inc.
TSRO
| $17.8M | 0.92% | 604,582 +133,300 | +28% | +$3.93M |
|
|
INFI
19
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $15.5M | 0.8% | 1,300,737 | – | – |
|
|
20
Puma Biotechnology
PBYI
$254M
| $12.3M | 0.63% | +117,991 | New | +$12.3M |
|
|
IDIX
21
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| $7.54M | 0.39% | 1,250,000 | – | – |
|
|
ACHN
22
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $5.85M | 0.3% | 1,779,340 | – | – |
|
|
ARIA
23
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $1.38M | 0.07% | 171,517 -1,215,654 | -88% | -$9.8M |
|